Bern M, Nilsen J, Ferrarese M, Sand KMK, Gjølberg TT, Lode HE, Davidson RJ, Camire RM, Bækkevold ES, Foss S, Grevys A, Dalhus B, Wilson J, Høydahl LS, Christianson GJ, Roopenian DC, Schlothauer T, Michaelsen TE, Moe MC, Lombardi S, Pinotti M, Sandlie I, Branchini A, Andersen JT(2020) An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics Sci Transl Med, 12(565) DOI 10.1126/scitranslmed.abb0580, PubMed 33055243
Nedal A, Ræder SB, Dalhus B, Helgesen E, Forstrøm RJ, Lindland K, Sumabe BK, Martinsen JH, Kragelund BB, Skarstad K, Bjørås M, Otterlei M(2020) Peptides containing the PCNA interacting motif APIM bind to the β-clamp and inhibit bacterial growth and mutagenesis Nucleic Acids Res, 48(10), 5540-5554 DOI 10.1093/nar/gkaa278, PubMed 32347931
Nilsen J, Trabjerg E, Grevys A, Azevedo C, Brennan SO, Stensland M, Wilson J, Sand KMK, Bern M, Dalhus B, Roopenian DC, Sandlie I, Rand KD, Andersen JT(2020) An intact C-terminal end of albumin is required for its long half-life in humans Commun Biol, 3(1), 181 DOI 10.1038/s42003-020-0903-7, PubMed 32313072
Contact information: Group leader Bjørn Dalhus, research scientist, Dr. scient. Department of Microbiology & Department of Medical Biochemstry Oslo University Hospital Rikshospitalet PO Box 4950 Nydalen NO-0424 Oslo, Norway Tel: +47 23070809 Fax: +47 23074061 E-mail: bjorn-dalhus@medisin.uio.no